Johanna BAKONYI,Steven Richard BRUNETTE,Delphine COLLIN,Robert Owen HUGHES,Xiang LI,Shuang LIANG,Robert SIBLEY,Michael Robert TURNER,Lifen WU,Qiang ZHANG
申请号：
US15426208
公开号：
US20180022749A1
申请日:
2017.02.07
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention encompasses compounds of the formula (I)wherein the variables are defined herein which are suitable for the modulation of RORγ and the treatment of diseases related to the modulation of RORγ. The present invention also encompasses processes of making compounds of formula (I) and pharmaceutical preparations containing them.
